JAB Medical Ltd 13337776 false 2022-05-01 2023-04-30 2023-04-30 The principal activity of the company is Property management Digita Accounts Production Advanced 6.30.9574.0 true true 13337776 2022-05-01 2023-04-30 13337776 2023-04-30 13337776 bus:OrdinaryShareClass1 2023-04-30 13337776 core:CurrentFinancialInstruments core:WithinOneYear 2023-04-30 13337776 core:LandBuildings 2023-04-30 13337776 bus:SmallEntities 2022-05-01 2023-04-30 13337776 bus:AuditExemptWithAccountantsReport 2022-05-01 2023-04-30 13337776 bus:FilletedAccounts 2022-05-01 2023-04-30 13337776 bus:SmallCompaniesRegimeForAccounts 2022-05-01 2023-04-30 13337776 bus:RegisteredOffice 2022-05-01 2023-04-30 13337776 bus:CompanySecretaryDirector1 2022-05-01 2023-04-30 13337776 bus:OrdinaryShareClass1 2022-05-01 2023-04-30 13337776 bus:PrivateLimitedCompanyLtd 2022-05-01 2023-04-30 13337776 countries:England 2022-05-01 2023-04-30 13337776 2022-04-30 13337776 core:LandBuildings 2022-04-30 13337776 2021-04-15 2022-04-30 13337776 2022-04-30 13337776 bus:OrdinaryShareClass1 2022-04-30 13337776 core:CurrentFinancialInstruments core:WithinOneYear 2022-04-30 13337776 core:LandBuildings 2022-04-30 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 13337776

JAB Medical Ltd

Unaudited Filleted Abridged Financial Statements

for the Year Ended 30 April 2023

 

JAB Medical Ltd

Contents

Company Information

1

Abridged Balance Sheet

2

Notes to the Unaudited Abridged Financial Statements

3 to 5

 

JAB Medical Ltd

Company Information

Director

Arabella Verity Ashe - Belton

Company secretary

Arabella Verity Ashe - Belton

Registered office

Charles Rippin & Turner
Middlesex House
130 College Road
Harrow
Middlesex
HA1 1BQ

Accountants

Charles Rippin & Turner
Middlesex House
130 College Road
Harrow
Middlesex
HA1 1BQ

 

JAB Medical Ltd

(Registration number: 13337776)
Abridged Balance Sheet as at 30 April 2023

Note

2023
£

2022
£

Fixed assets

 

Tangible assets

4

525,418

525,418

Creditors: Amounts falling due within one year

(555,433)

(555,433)

Total assets less current liabilities

 

(30,015)

(30,015)

Accruals and deferred income

 

(1,000)

(600)

Net liabilities

 

(31,015)

(30,615)

Capital and reserves

 

Called up share capital

6

1

1

Retained earnings

(31,016)

(30,616)

Shareholders' deficit

 

(31,015)

(30,615)

For the financial year ending 30 April 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

All of the company’s members have consented to the preparation of an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 6 April 2024
 

.........................................
Arabella Verity Ashe - Belton
Company secretary and director

 

JAB Medical Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 April 2023

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Charles Rippin & Turner
Middlesex House
130 College Road
Harrow
Middlesex
HA1 1BQ

These financial statements were authorised for issue by the director on 6 April 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

 

JAB Medical Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 April 2023

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 0 (2022 - 0).

 

JAB Medical Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 April 2023

4

Tangible assets

Land and buildings
£

Total
£

Cost or valuation

At 1 May 2022

525,418

525,418

At 30 April 2023

525,418

525,418

Depreciation

Carrying amount

At 30 April 2023

525,418

525,418

At 30 April 2022

525,418

525,418

Included within the net book value of land and buildings above is £525,418 (2022 - £525,418) in respect of freehold land and buildings.
 

5

Debtors

Debtors includes £Nil (2022 - £Nil) due after more than one year.

6

Share capital

Allotted, called up and fully paid shares

2023

2022

No.

£

No.

£

Ordinary shares of £1 each

1

1

1

1